These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 26265556)
21. Effect of early conversion to everolimus together with prophylaxis with valganciclovir in the prevention of cytomegalovirus infection in heart transplant recipients. Díaz Molina B; Velasco Alonso E; Lambert Rodríguez JL; Rodríguez Bernardo MJ; Rozado Castaño J; Padrón Encalada R; Martín Fernández M; Pun Chinchai F; Colunga Blanco S; García Campos A Transplant Proc; 2015; 47(1):130-1. PubMed ID: 25645790 [TBL] [Abstract][Full Text] [Related]
22. Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs. Flechner SM; Goldfarb D; Solez K; Modlin CS; Mastroianni B; Savas K; Babineau D; Kurian S; Salomon D; Novick AC; Cook DJ Transplantation; 2007 Apr; 83(7):883-92. PubMed ID: 17460558 [TBL] [Abstract][Full Text] [Related]
23. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients. Singh N Clin Infect Dis; 2001 Mar; 32(5):742-51. PubMed ID: 11229841 [TBL] [Abstract][Full Text] [Related]
24. Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation. Slifkin M; Ruthazer R; Freeman R; Bloom J; Fitzmaurice S; Fairchild R; Angelis M; Cooper J; Barefoot L; Rohrer R; Snydman DR Liver Transpl; 2005 Dec; 11(12):1597-602. PubMed ID: 16315314 [TBL] [Abstract][Full Text] [Related]
25. Cytomegalovirus disease after liver transplantation: diagnostics and therapy. Wiens M; Schmidt CA; Lohmann R; Oettle H; Blumhardt G; Neuhaus P Transplant Proc; 1993 Aug; 25(4):2673-4. PubMed ID: 8395108 [No Abstract] [Full Text] [Related]
30. A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients. Madan RP; Campbell AL; Shust GF; Kahn AR; Wistinghausen B; Posada R; Kerkar N; Shneider BL; Emre S; Herold BC Transplantation; 2009 May; 87(9):1318-24. PubMed ID: 19424031 [TBL] [Abstract][Full Text] [Related]
31. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation. Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354 [TBL] [Abstract][Full Text] [Related]
32. Editorial commentary: Use of valganciclovir for prevention and treatment of cytomegalovirus disease. Snydman DR Clin Infect Dis; 2008 Jan; 46(1):28-9. PubMed ID: 18171209 [No Abstract] [Full Text] [Related]
33. Effective strategies to prevent cytomegalovirus disease after renal transplantation. Chapman JR Transplant Proc; 2000 Nov; 32(7):1508-9. PubMed ID: 11119809 [No Abstract] [Full Text] [Related]
34. A short-term preemptive treatment for cytomegalovirus infection in seropositive patients after liver transplantation. Dahiya D; Lee CF; Chan KM; Wu TJ; Chou HS; Cheng SS; Lee WC J Hepatobiliary Pancreat Sci; 2011 Jan; 18(1):32-8. PubMed ID: 20499109 [TBL] [Abstract][Full Text] [Related]
36. Cytomegalovirus prophylaxis by ganciclovir followed by high-dose acyclovir in renal transplantation: a randomized, controlled trial. Pouteil-Noble C; Megas F; Chapuis F; Bosshard S; Colin C; Hadj-Aissa A; Pozet N; Martin X; Lefrançois N; Garnier JL; Aymard M; Touraine JL Transplant Proc; 1996 Oct; 28(5):2811. PubMed ID: 8908072 [No Abstract] [Full Text] [Related]
37. Cytomegalovirus infection in kidney transplantation: prophylaxis and management. Bulinski P; Toledo-Pereyra LH; Dalal S; Hernandez G Transplant Proc; 1996 Dec; 28(6):3310-1. PubMed ID: 8962286 [No Abstract] [Full Text] [Related]
38. Cytomegalovirus prevention strategies: the case for prophylaxis. Snydman DR Am J Transplant; 2009 May; 9(5):1254. PubMed ID: 19422353 [No Abstract] [Full Text] [Related]